Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Sep 16, 2014; 2(9): 415-421
Published online Sep 16, 2014. doi: 10.12998/wjcc.v2.i9.415
Published online Sep 16, 2014. doi: 10.12998/wjcc.v2.i9.415
Evidence of other atherosclerotic vascular disease |
Renal disease |
Abnormal resting electrocardiogram |
Diabetes complications including autonomic neuropathy |
Age > 45 yr |
Male sex |
Traditional risk factors |
Blood pressure |
Dyslipidemia |
Smoking |
Inactivity |
Abdominal obesity |
Novel cardiac risk factors |
C-reactive protein |
Homocysteine |
Lipoprotein(a) |
Cardiovascular disease is the leading cause of mortality in patients with T2DM |
Control of cardiovascular risk factors has been shown to significantly reduce the incidence of cardiovascular disease in T2DM patients |
Control level of cardiovascular risk factors in patients with T2DM in clinical practice is poor |
Systematic screening of cardiovascular disease has not been shown to improve the prognosis of patients with T2DM |
In patients with atypical symptoms or ECG abnormalities, cardiovascular disease screening is warranted |
- Citation: Chillarón JJ, Roux JAFL, Benaiges D, Pedro-Botet J. Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen. World J Clin Cases 2014; 2(9): 415-421
- URL: https://www.wjgnet.com/2307-8960/full/v2/i9/415.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v2.i9.415